Insider · CIK 0002033869
Marc Banjak
officer
Files at IBIO (iBio, Inc.). First filing Jan 13, 2025, latest Jan 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$25k bought, $0 sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IBIO: iBio, Inc.
IBIOOct 9, 2026 · close 0.87
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | iBio, Inc. | $25k 9,191 shares | +490% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 20, 2025 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +55,000 | $0.00 | $0 | 55,000 | Oct 22, 2025 |
| Feb 21, 2025 | IBIO iBio, Inc. | AGrant or award Stock Option (right to buy)derivative | +71,000 | $0.00 | $0 | 71,000 | Feb 24, 2025 |
| Jan 10, 2025 | IBIO iBio, Inc. | POpen-market purchase Common Stock | +9,191 | $2.72 | $25k | 11,066 | Jan 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.